Amgen Buys Icelandic Gene Pioneer Decode for $415 Million

10.12.2012 - U.S. biotechnology group Amgen has agreed to buy unlisted Decode Genetics, a pioneer in gene research, for $415 million to boost its drive to develop better targeted drugs. Founded...